Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly.
Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly.
复制标题
DOI:
10.1016/j.biopsych.2016.10.005
复制
发表时间:
2017-06-01
影响因子:
10.6
通讯作者:
Kippin TE
中科院分区:
文献类型:
--
作者:
Szumlinski KK;Lominac KD;Campbell RR;Cohen M;Fultz EK;Brown CN;Miller BW;Quadir SG;Martin D;Thompson AB;von Jonquieres G;Klugmann M;Phillips TJ;Kippin TE
The high prevalence and severity of methamphetamine (MA) abuse demands greater neurobiological understanding of its etiology. Here, we conducted immunoblotting and in vivo microdialysis procedures in Methamphetamine High/Low Drinking (MAH/LDR) mice, as well as in isogenic C57BL/6J mice that varied in their MA-preference/taking, to examine the glutamate underpinnings of MA abuse vulnerability. Neuropharmacological and Homer2 knock-down approaches were also employed in C57BL/6J mice to confirm the role for nucleus accumbens glutamate/Homer2 expression in MA preference/aversion. We identified a hyper-glutamatergic state within the nucleus accumbens (NAC) as a biochemical trait corresponding with both genetic and idiopathic vulnerability for high MA-preference and -taking. We also confirmed that subchronic, subtoxic MA experience elicits a hyper-glutamatergic state within the NAC during protracted withdrawal, characterized by elevated mGlu1/5 receptor function and Homer2 receptor-scaffolding protein expression. A high MA-preferring phenotype was recapitulated by elevating endogenous glutamate within the NAC shell of mice and we reversed MA-preference/taking by lowering endogenous glutamate and/or Homer2 expression within this subregion. Our data point to an idiopathic, genetic or drug-induced hyper-glutamatergic state within the NAC as a mediator of MA addiction vulnerability.